PUBLISHER: Allied Market Research | PRODUCT CODE: 1414878
PUBLISHER: Allied Market Research | PRODUCT CODE: 1414878
According to a new report published by Allied Market Research, titled, "Automated Microscopy Market," The automated microscopy market was valued at $7.1 billion in 2022, and is estimated to reach $13 billion by 2032, growing at a CAGR of 6.4% from 2023 to 2032.
The major key factor that contributes toward the market growth includes surge in adoption of automated microscope owing to its high precision, technological advancement in automated microscopy technology. The healthcare industry has witnessed a remarkable surge in the adoption of automated microscopes, driven primarily by their unparalleled precision and numerous advantages. Automated microscopes are equipped with advanced imaging and analytical capabilities that offer high levels of precision and consistency in a wide range of medical applications, from diagnosing diseases to conducting research. Automated microscopes not only enhance the accuracy of diagnoses but also significantly reduce the margin of error, making them invaluable tools for healthcare professionals. Automated microscopes are capable of handling large volumes of samples efficiently and can automatically scan, capture, and analyze microscopic images, reducing the need for manual intervention. This not only saves time but also enhances productivity, making healthcare operations more cost-effective. Some automated microscopes used for medical diagnosis are BioTek Lionheart LX Automated Microscope IVD (Agilent Technologies, Inc.) and BioTek Lionheart FX Automated Microscope.
Technological advancements such as integration of imaging software in the automated microscopes have emerged as a major driver for the automated microscopy market. This technological advancement has revolutionized the way healthcare professionals and researchers analyze cellular and molecular structures, thereby facilitating more accurate diagnoses and cutting-edge research. The incorporation of sophisticated imaging software allows for the automation of complex microscopy processes, such as image acquisition, analysis, and data interpretation. This automation not only enhances the efficiency of healthcare laboratories but also reduces the risk of human error, ultimately improving the reliability and consistency of results. For instance, in 2022, the National Library of Medicine conducted a study to evaluate the GIANI (General Image Analysis of Nuclei-based Images) image analysis software for automated analysis for microscopes. The study anticipated the GIANI will be a useful tool for researchers in various biomedical fields. Thus, the technological advancement in automated microscopy is expected to drive the growth of the market.
However, high cost of automated microscopes is the major restraint for the market growth. In addition, integration of artificial intelligence in the automated microscopy presents major growth opportunity for the market growth in the future.
The global automated microscopy market is segmented on the basis of product, application, end use, and region. By product, the market is classified into optical microscope, electron microscope and scanning probe microscope. By application, the market is categorized into medical diagnosis, life science research and drug discovery and development. Based on end user, the market is segmented into diagnostic laboratories, research laboratories and pharmaceutical industry. Region-wise, the market is analyzed across North America (the U.S., Canada, and Mexico), Europe (Germany, France, the UK, Italy, Spain, and rest of Europe), Asia-Pacific (Japan, China, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).
North America accounted for a majority of the global automated microscopy market share in 2022 and is anticipated to remain dominant during the forecast period. This is attributed to rise in prevalence of chronic disorder, strong presence of key players, and high number of tattoo removal procedures. However, Asia-Pacific is anticipated to witness fastest growth during the forecast period, owing to increase in prevalence of ophthalmic disorders, and rise in number of hospitals & clinics.
Additional benefits you will get with this purchase are:
Possible Customization with this report (with additional cost and timeline, please talk to the sales executive to know more)